Bill

Bill > HB1523


MD HB1523

MD HB1523
Alcohol, Tobacco, and Cannabis Commission - Unauthorized Consumable Products - Enforcement and Seizure


summary

Introduced
02/13/2026
In Committee
04/09/2026
Crossed Over
03/23/2026
Passed
05/12/2026
Dead
Signed/Enacted/Adopted
05/12/2026

Introduced Session

2026 Regular Session

Bill Summary

Altering the violations of law with respect to which the Field Enforcement Division of the Alcohol, Tobacco, and Cannabis Commission is authorized to issue a citation or charging document; prohibiting a retailer from distributing, selling, exposing for sale, or advertising for sale unauthorized consumable products; authorizing the Executive Director of the Commission to seize, confiscate, or destroy unauthorized consumable products and certain other products; etc.

AI Summary

This bill expands the enforcement powers of the Alcohol, Tobacco, and Cannabis Commission's Field Enforcement Division by allowing them to issue citations for violations related to certain health articles concerning tianeptine, kratom, and phenibut products, in addition to existing laws. It also prohibits retailers from distributing, selling, or advertising "unauthorized consumable products," which are defined to include specific products like tianeptine, kratom, and phenibut that do not comply with state regulations, as well as any consumable product containing a poisonous substance designated by the Secretary of Health. The Executive Director of the Commission is authorized to seize, confiscate, or destroy these unauthorized products and certain other items, such as products containing specific amounts of 7-hydroxymitragynine or tianeptine. Retailers found violating these provisions face misdemeanor charges, fines, potential license suspension or revocation, and civil liability for damages. The bill also clarifies that proof of displaying or offering an unauthorized consumable product for sale is considered prima facie evidence of selling it, and it establishes specific rules for the advertising and marketing of kratom and phenibut products, particularly concerning minors. Finally, the Maryland Department of Health is required to notify the Commission about changes in the regulatory status of these products.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (19)

Last Action

Approved by the Governor - Chapter 354 (on 05/12/2026)

Taxonomy

Banking, Finance, and Domestic Commerce
  • ‐ Consumer Safety and Consumer Fraud
Health
  • ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
  • ‐ Illegal Drugs and Narcotics Control

bill text


bill summary

Loading...

bill summary

Loading...
Loading...